WST icon

West Pharmaceutical

218.18 USD
+3.05
1.42%
At close Apr 23, 4:00 PM EDT
After hours
218.18
+0.00
0.00%
1 day
1.42%
5 days
2.87%
1 month
-5.92%
3 months
-36.57%
6 months
-23.83%
Year to date
-33.56%
1 year
-44.09%
5 years
16.41%
10 years
285.48%
 

About: West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Employees: 10,600

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

150% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 10 (+6) [Q4]

32% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 78

14% more repeat investments, than reductions

Existing positions increased: 289 | Existing positions reduced: 254

13% more capital invested

Capital invested by funds: $20.2B [Q3] → $22.8B (+$2.57B) [Q4]

2.73% more ownership

Funds ownership: 93.28% [Q3] → 96.01% (+2.73%) [Q4]

2% more funds holding

Funds holding: 720 [Q3] → 732 (+12) [Q4]

44% less call options, than puts

Call options by funds: $77.4M | Put options by funds: $139M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$275
26%
upside
Avg. target
$300
38%
upside
High target
$325
49%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Evercore ISI Group
Daniel Markowitz
0% 1-year accuracy
0 / 2 met price target
26%upside
$275
Outperform
Initiated
18 Mar 2025
Keybanc
Paul Knight
0% 1-year accuracy
0 / 9 met price target
49%upside
$325
Overweight
Maintained
14 Feb 2025

Financial journalist opinion

Based on 24 articles about WST published over the past 30 days

Positive
Zacks Investment Research
1 day ago
Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings?
West Pharmaceutical Services' first-quarter results are likely to reflect growth amid pharma stabilization, biologics rebound & contract manufacturing gains.
Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings?
Neutral
Accesswire
2 days ago
WST ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by West Pharmaceutical Services, Inc.
NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
WST ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by West Pharmaceutical Services, Inc.
Neutral
Accesswire
5 days ago
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)
Negative
Zacks Investment Research
6 days ago
Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline
Neutral
Accesswire
6 days ago
West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
NEW YORK, NY / ACCESS Newswire / April 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Neutral
Accesswire
1 week ago
An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses
Neutral
Accesswire
1 week ago
West Pharmaceutical Services, Inc. Being Investigated on Behalf of West Pharmaceutical Services, Inc. Investors. Contact Levi & Korsinsky For Details.
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
West Pharmaceutical Services, Inc. Being Investigated on Behalf of West Pharmaceutical Services, Inc. Investors. Contact Levi & Korsinsky For Details.
Neutral
Accesswire
1 week ago
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
Neutral
Accesswire
1 week ago
WST ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of West Pharmaceutical Services, Inc. Shareholders Who Lost Money
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
WST ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of West Pharmaceutical Services, Inc. Shareholders Who Lost Money
Neutral
Accesswire
1 week ago
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about Securities Fraud Investigation - WST
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about Securities Fraud Investigation - WST
Charts implemented using Lightweight Charts™